{
    "clinical_study": {
        "@rank": "57012", 
        "acronym": "NSRHCXCA", 
        "arm_group": [
            {
                "arm_group_label": "Nerve sparing radical hysterectomy group", 
                "arm_group_type": "Experimental", 
                "description": "sparing hypogastric nerve\nsparing pelvic splanchnic nerve ad pelvic plexus in cardinal ligament\nsparing distal part of hypogastric nerve and vesical branch of pelvic splanchnic nerve"
            }, 
            {
                "arm_group_label": "Radical hysterectomy group", 
                "arm_group_type": "Active Comparator", 
                "description": "Conventional radical hysterectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "To develope nerve sparing radical hysterectomy for treatment of cervical cancer to minimize\n      the complication of radical hysterectomy and to maximize quality of life and to evaluate the\n      feasibility and efficacy by prospective randomized trial."
        }, 
        "brief_title": "The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer", 
        "condition": "Cervical Cancer", 
        "condition_browse": {
            "mesh_term": "Uterine Cervical Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically diagnosed cervical cancer\n\n          -  FIGO stage IA2-IIA\n\n          -  Diameter of tumor is less than 4cm on exam\n\n          -  One of hitological type written below squamous cell carcinoma, adenocarcinoma,\n             adenosquamous cell carcinoma\n\n          -  Age between 18-70\n\n          -  Performance status; GOG 0-1\n\n          -  Normal hematological, hepatic, nephrologic function WBC \u2265 4000 cells/mm3 Platelet \u2265\n             100,000 /mm3 Hemoglobin \u2265 8.0 gm/dL Serum creatinin \u2264 1.3 mg/dL Serum bilirubin \u2264 1.5\n             mg/dL SBOT/SGPT and Alkaline phoaphatase < normal X 3\n\n          -  Patient with informed consent\n\n        Exclusion creteria:\n\n          -  Small cell carcinoma\n\n          -  Unable to perform surgery because of severe underlying medical disease severe heart\n             disease, congestive heart failure/severe pulmonary disease, pulmonary failure/ active\n             bacterial infectio which needs non oral antibiotic therapy/ associated with other\n             severe medical diseases\n\n          -  Prior chemotherapy or radiotherapy\n\n          -  Severe bladder funtion abnormality\n\n          -  Double primary malignant tumor\n\n          -  Psychiatric problems\n\n          -  Pregnant or breast feeding status\n\n          -  Legally unable to participate clinical trial\n\n          -  When there is a Doctor's decision that patient is unable to participate clinical\n             trial"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "146", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893333", 
            "org_study_id": "NSRH_Cxca"
        }, 
        "intervention": {
            "arm_group_label": [
                "Nerve sparing radical hysterectomy group", 
                "Radical hysterectomy group"
            ], 
            "description": "Nerve sparing radical hysterectomy\nsparing hypogastric nerve\nsparing pelvic splanchnic nerve ad pelvic plexus in cardinal ligament\nsparing distal part of hypogastric nerve and vesical branch of pelvic splanchnic nerve", 
            "intervention_name": "Nerve sparing radical hysterectomy", 
            "intervention_type": "Procedure", 
            "other_name": "Nerve sparing radical hysterectomy"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cervical cancer", 
            "nerve sparing radical hysterectomy"
        ], 
        "lastchanged_date": "July 2, 2013", 
        "location": {
            "contact": {
                "email": "jhnam@amc.seoul.kr", 
                "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
                "phone": "82-2-3010-3633"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy and Safety of Nerve-sparing Radical Hysterectomy in Cervical Cancer", 
        "overall_contact": {
            "email": "jhnam@amc.seoul.kr", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "phone": "82-2-3010-3633"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Remove foley catheter and measure the residual urine volume Measure how long it took to be residual urine volume under 50 mL", 
            "measure": "Incidence of bladder dysfunction after surgery", 
            "safety_issue": "No", 
            "time_frame": "5 days after the surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893333"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Joo-Hyun Nam", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "rectal & anal function after surgery", 
                "safety_issue": "No", 
                "time_frame": "6, 12 months after surgery"
            }, 
            {
                "measure": "Sexual function", 
                "safety_issue": "No", 
                "time_frame": "6, 12 months after surgery"
            }, 
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "6, 12 months after surgery"
            }, 
            {
                "measure": "operative time", 
                "safety_issue": "No", 
                "time_frame": "immediately after surgery"
            }, 
            {
                "measure": "amount of bleeding in operation", 
                "safety_issue": "No", 
                "time_frame": "immediately after surgery"
            }, 
            {
                "measure": "frequency of blood transfusion", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "amount of blood transfusion", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "postoperative complication", 
                "safety_issue": "No", 
                "time_frame": "within 1 month after surgery"
            }, 
            {
                "measure": "time from surgery to return to work", 
                "safety_issue": "No", 
                "time_frame": "within 1 month after surgery"
            }, 
            {
                "measure": "management cost", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "size of resected parametrial tissue", 
                "safety_issue": "No", 
                "time_frame": "immediately after surgery"
            }, 
            {
                "measure": "2year disease free survival", 
                "safety_issue": "No", 
                "time_frame": "2 year after treatment"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}